Taking peopleNo phase
ALTo endogrAft Italian Registry
Key facts
- Who runs it
- Gianmarco de Donato
- Where
- Italy2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 300 people, planned
- Started
- 1 Jan 2022
- Expected to end
- 31 Dec 2028
- Type of study
- Observational
- Treatments tested
- ALTO endograft implantation
- Record updated
- 20 July 2023
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Elective AAA patients that should be treated by standard EVAR, according to Endologix Alto endograft device's Instructions For Use
- Patient is willing to comply with specified follow-up evaluations at the specified times for the duration of the study
- Patient is >18 years old
- Patient, or their legal representative, understands the nature of the procedure and provides written informed consent, prior to enrollment in the study
Who cannot take part
- Patients for whom antiplatelet therapy, anticoagulants or antihypertensive drug are contraindicated
- Patients with a history of prior life-threatening contrast medium reaction
- EVAR performed in Urgent/Emergent setting
- Patients treated outside Endologix Alto endograft device's Instructions For Use
- Patients refusing treatment
- Life expectancy of less than follow-up period; AAA: abdominal aortic aneurysm; EVAR: abdominal endovascular aneurysm
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of present study is to evaluate intraoperative, peri-operative, and post-operative results in patients treated by the ALTO stent graft (Endologix Inc. Irvine, Calif) for elective Abdominal Aortic Aneurysm repair in a multicentric consecutive experience.
The group in the trial
- EVAR group
All consecutive eligible patients submitted to EVAR by Alto Endovascular AAA implantation will be included in analysis. Patients will be submitted to EVAR procedures on the basis of their own preferences, anatomical features, and operators experience.
Treatment: ALTO endograft implantation
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 20 July 2023